Hematopoiesis News 10.42 October 29, 2019 | |
| |
TOP STORYResearchers generated mouse models expressing inducible histone H3 lysine-to-methionine (K-to-M) mutants, which globally inhibited methylation at specific sites. Mice expressing H3K36M developed severe anemia with arrested erythropoiesis, a marked HSC defect, and rapid lethality. [Nat Cell Biol] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Thiopurine-Mediated Impairment of Hematopoietic Stem and Leukemia Cells in Nudt15R138C Knock-In Mice Scientists established knock-in mice harboring p.Arg138Cys (Nudt15R138C), which corresponded to the human polymorphism. A clinically relevant dose of mercaptopurine induced lethal cytopenia in Nudt15R138C-harboring mice. [Leukemia] Abstract BHRF1 interacted with the cellular pro-apoptotic BCL-2 proteins, BIM, BID, PUMA and BAK, but its capability to inhibit apoptosis could not be mapped solely to one of these interactions, suggesting plasticity is a key feature of BHRF1. [Cell Death Differ] Abstract Interleukin-6 Signaling Regulates Hematopoietic Stem Cell Emergence The authors showed that interleukin-6R (IL6R) via IL6 was required and sufficient for HSC generation. They found that Notch activated IL6R by regulating its expression in the hemogenic endothelium and in HSCs. [Exp Mol Med] Full Article Investigators explored whether a hematopoietic Npc1 mutation, induced via bone marrow transplantation, influenced gut microbiota composition in low-density lipoprotein receptor knockout (Ldlr-/-) mice fed a high-fat, high-cholesterol diet for 12 weeks. [Sci Rep] Full Article Researchers demonstrated that a microfluidic transduction device could improve the efficiency of lentiviral transduction for both T-cell and HSC targets by greater than two fold relative to static controls. [Sci Rep] Full Article Scientists found that while mouse cytomegalovirus could infect a broad range of hematopoietic bone marrow cells, latent virus is only detectable in HSCs, myeloid progenitor cells, monocytes and dendritic cell-enriched cell subsets. [J Gen Virol] Abstract CLINICAL RESEARCHInvestigators demonstrated that regulatory T cells (Tregs) were more dramatically decreased in bone marrow compared with those in peripheral blood from acute graft-versus-host disease patients and that bone marrow Treg defects were negatively associated with hematopoietic reconstitution. [Cell Mol Immunol] Full Article A prospective multicentre study was conducted to evaluate the immunogenicity of the inactivated influenza vaccine in children who have undergone HSC transplant compared with healthy age-matched controls. [Bone Marrow Transplant] Abstract Subscribe to one of our other 19 science newsletters such as Cord Blood News & Cell Therapy News. | |
| |
REVIEWSMyeloid-Derived Suppressor Cells in Hematological Malignancies: Friends or Foes The authors review the various characteristics and functions of myeloid-derived suppressor cells (MDSCs), as well as the potential therapeutic applications of MDSCs in hematological malignancies, including lymphoma, multiple myeloma, leukemia, and hematopoietic stem cell transplantation. [J Hematol Oncol] Full Article Visit our reviews page to see a complete list of reviews in the hematopoiesis research field. | |
| |
INDUSTRY NEWSPascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia. [Pascal Biosciences, Inc. (GlobeNewswire, Inc.)] Press Release The National Institutes of Health and the Bill and Melinda Gates Foundation will together invest at least $200 million over the next four years to develop gene-based cures for sickle cell disease and HIV with an attribute even rarer in the world of genetic medicine than efficacy. [National Institutes of Health (STAT)] Press Release Actinium Pharmaceuticals, Inc. announced key interim findings from the pivotal Phase III SIERRA trial of Iomab-B, including feasibility and safety data, at 50% of total patient enrollment. [Actinium Pharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSUCL to Phase Out Single-Use Plastics, Including Pipette Tips University College London made a series of pledges last week to cut down on plastic waste, help mitigate climate change, and make its research and teaching facilities more environmentally sustainable. [TheScientist] Editorial A university commission announced this week it had found evidence of “extensive and severe scientific misconduct” by Christof Sohn, director of the women’s clinic at Heidelberg University Hospital in Germany and the lead researcher behind a highly publicized but questionable blood test designed to detect breast cancer. [ScienceMagazine] Editorial
| |
EVENTSNEW The Life of the Skeleton from Embryonic Development to Aging Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Assistant/Associate Professor – Hematology & Oncology (UC Davis School of Medicine) NEW Associate/Professor – Hematology & Oncology (UC Davis School of Medicine) PhD Project – Physical Biology of Blood Stem Cells (University of York) Postdoctoral Fellowship (Versiti Blood Research Institute) Postdoctoral Research Fellowship (New York Blood Center) Faculty Positions – Gene Editing (Indiana University School of Medicine) Postdoctoral Fellowship – Hematopoietic Cell Transplantation (University of Maryland) Postdoctoral Scholar – Hematopoietic Cells (Penn State University) Postdoctoral Fellowship – Leukemia Pathogenesis (BC Cancer) Faculty – Hematopoietic Biology and Malignancy (MD Anderson Cancer Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Hematopoiesis News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|